A phase 1, single-center, double-blind study of AM103 in healthy volunteers.

Trial Profile

A phase 1, single-center, double-blind study of AM103 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2013

At a glance

  • Drugs GSK 2190914 (Primary)
  • Indications Asthma; Cardiovascular disorders; Respiratory tract disorders
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Amira Pharmaceuticals
  • Most Recent Events

    • 27 Dec 2011 Actual initiiation date 18 Jun 2007 added and trial location (Netherlands) identified as reported by ISRCTN.
    • 27 Dec 2011 Actual end date 31 Oct 2007 added as reported by ISRCTN.
    • 02 Nov 2007 Status change from initiated to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top